Purchase Order 15B10726P00000042
- Not listed
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, received a purchase order award from the Federal Correctional Institution Cumberland valued at $1,719.52 on October 1, 2025. This firm fixed-price contract, with an ultimate completion date of December 18, 2025, represents a direct procurement with no set-aside designation. The award supports the Bureau of Prisons' pharmaceutical supply requirements, consistent with...
- The U.S. Federal Correctional Institution Cumberland awarded a firm fixed-price delivery order contract to McKesson Corporation, a large healthcare services and information technology company, to provide pharmaceutical products and medical supplies. The $102,825.98 contract has an ultimate completion date of August 31, 2025 and does not utilize any set-aside designations. McKesson has a significant presence in providing medical and pharmaceutical support to various federal agencies, including...
- The Department of Justice's Federal Correctional Institution Cumberland has awarded a $1,853.47 firm fixed price purchase order to McKesson Corporation, a healthcare services and IT company, to provide open market pharmaceuticals for the inmate population. The award has a completion date of September 30, 2024 and does not utilize any set-aside designation. McKesson has previously provided a range of pharmaceutical products and services to various federal agencies, including the Bureau of...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Cumberland awarded Mckesson Corporation, doing business as Mckesson, a $619,240 purchase order contract to deliver open market pharmaceuticals from August through September 2023. As one of the largest providers of healthcare products and services to correctional facilities, Mckesson will supply a range of prescription and over-the-counter medications to the Bureau of Prisons institution located in Irving, Texas. The...
- Mckesson Corporation received a firm fixed-price purchase order valued at $1,374.34 from the Federal Correctional Institution Cumberland, a civilian agency under the Department of Justice, for pharmaceutical products. The contract was awarded on November 1, 2025, with an ultimate completion date of December 18, 2025. No set-aside designation was used for this procurement. The place of performance is Mckesson's location in Irving, Texas. This purchase order represents a routine pharmaceutical...
- McKesson Corporation was awarded a Delivery Order contract by the Federal Correctional Institution Cumberland, a component of the Bureau of Prisons under the Department of Justice, on October 1, 2025. The contract, valued at $8,904.34 with a firm fixed price structure, calls for the delivery of materials to support correctional facility operations. The performance location is McKesson's headquarters in Irving, Texas, with an ultimate completion date of October 31, 2025. No set-aside...
- Mckesson Corporation will provide pharmaceutical supplies to the Federal Bureau of Prisons under a $450,000 firm fixed-price purchase order awarded by the Department of Justice. As one of the largest pharmaceutical distributors in the U.S., Mckesson will deliver drugs and medical supplies to the Federal Correctional Institution in Cumberland, Maryland in support of the Bureau of Prisons' healthcare programs at that facility. The single-award order runs from December 1, 2023 through December...
- McKesson Corporation received a delivery order contract award from the Federal Correctional Institution Cumberland, a civilian agency under the Department of Justice, on December 1, 2025. The contract, valued at $9,000 and utilizing firm fixed-price pricing, is scheduled for completion by December 31, 2025. No set-aside designation was used for this award. The performance location is McKesson's headquarters in Irving, Texas. This delivery order represents a continuation of McKesson's ongoing...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Cumberland awarded a $202,063.69 firm fixed price delivery order contract to Mckesson Corporation, a healthcare services and information technology company, to provide pharmaceuticals. This delivery order was issued against an existing indefinite delivery/indefinite quantity contract vehicle. No set-aside designations were used. Mckesson has provided a range of pharmaceutical products and services to federal agencies...
- Mckesson Corporation will provide pharmaceutical products to the Federal Bureau of Prisons under a firm fixed-price purchase order valued at approximately $406,000. The contract was awarded by the Bureau of Prisons' Federal Correctional Institution in Cumberland, Maryland to fulfill its pharmaceutical needs through December 2023. McKesson will deliver the products from its distribution center in Irving, Texas. No subcontractors or set-aside designations were specified. This order is likely...
The Federal Correctional Institution Cumberland awarded a $3,000 purchase order to McKesson Corporation on December 1, 2025, with a completion date of December 31, 2025. This firm fixed-price contract, which carries no set-aside designation, procures pharmaceutical products from McKesson's Irving, Texas location. As a major healthcare services and pharmaceutical distribution company, McKesson serves as a critical supplier to the Bureau of Prisons within the Department of Justice, providing controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals to correctional facilities nationwide. This purchase order represents a routine pharmaceutical procurement for the federal correctional system. McKesson maintains an extensive history of federal contract awards across multiple government agencies, including the Department of Veterans Affairs, Department of Health and Human Services' Indian Health Service, and Department of Homeland Security. The company also holds a significant $25.5 million Blanket Purchase Agreement with Customs and Border Protection covering medical, dental, and surgical supplies through September 2028, underscoring its established role as a trusted supplier of healthcare products to federal agencies managing complex medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/18/25 |